BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34018294)

  • 1. 10-year evaluation of the use of medical abortion through telemedicine: a retrospective cohort study.
    Nortén H; Ilozumba O; Wilkinson J; Gemzell-Danielsson K; Gomperts R
    BJOG; 2022 Jan; 129(1):151-159. PubMed ID: 34018294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine.
    Gomperts R; Petow SA; Jelinska K; Steen L; Gemzell-Danielsson K; Kleiverda G
    Acta Obstet Gynecol Scand; 2012 Feb; 91(2):226-31. PubMed ID: 21950492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study.
    Aiken A; Lohr PA; Lord J; Ghosh N; Starling J
    BJOG; 2021 Aug; 128(9):1464-1474. PubMed ID: 33605016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland.
    Aiken ARA; Digol I; Trussell J; Gomperts R
    BMJ; 2017 May; 357():j2011. PubMed ID: 28512085
    [No Abstract]   [Full Text] [Related]  

  • 5. Provision of medical abortion using telemedicine in Brazil.
    Gomperts R; van der Vleuten K; Jelinska K; da Costa CV; Gemzell-Danielsson K; Kleiverda G
    Contraception; 2014 Feb; 89(2):129-33. PubMed ID: 24314910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedicine for medical abortion: a systematic review.
    Endler M; Lavelanet A; Cleeve A; Ganatra B; Gomperts R; Gemzell-Danielsson K
    BJOG; 2019 Aug; 126(9):1094-1102. PubMed ID: 30869829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Anger HA; Raymond EG; Grant M; Haskell S; Boraas C; Tocce K; Banks J; Coplon L; Shochet T; Platais I; Winikoff B
    Contraception; 2021 Dec; 104(6):659-665. PubMed ID: 34329607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated With Use of an Online Telemedicine Service to Access Self-managed Medical Abortion in the US.
    Aiken ARA; Starling JE; Gomperts R
    JAMA Netw Open; 2021 May; 4(5):e2111852. PubMed ID: 34019085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of women living in Hungary seeking a medical abortion online.
    Les K; Gomperts R; Gemzell-Danielsson K
    Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):360-362. PubMed ID: 29164948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical abortion provided by telemedicine to women in Latin America: complications and their treatment].
    Larrea S; Palència L; Perez G
    Gac Sanit; 2015; 29(3):198-204. PubMed ID: 25770915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes before and after Ohio's Law Mandating Use of the FDA-Approved Protocol for Medication Abortion: A Retrospective Cohort Study.
    Upadhyay UD; Johns NE; Combellick SL; Kohn JE; Keder LM; Roberts SC
    PLoS Med; 2016 Aug; 13(8):e1002110. PubMed ID: 27575488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abortion surveillance--United States, 2009.
    Pazol K; Creanga AA; Zane SB; Burley KD; Jamieson DJ;
    MMWR Surveill Summ; 2012 Nov; 61(8):1-44. PubMed ID: 23169413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: A population based study.
    Aiken ARA; Romanova EP; Morber JR; Gomperts R
    Lancet Reg Health Am; 2022 Jun; 10():. PubMed ID: 35755080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple induced abortions as risk factor for ectopic pregnancy. A prospective study.
    Skjeldestad FE; Gargiullo PM; Kendrick JS
    Acta Obstet Gynecol Scand; 1997 Aug; 76(7):691-6. PubMed ID: 9292646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
    Thonneau P; Fougeyrollas B; Spira A
    Fertil Steril; 1994 Apr; 61(4):627-31. PubMed ID: 7512053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of abortion and unintended pregnancy in India, 2015.
    Singh S; Shekhar C; Acharya R; Moore AM; Stillman M; Pradhan MR; Frost JJ; Sahoo H; Alagarajan M; Hussain R; Sundaram A; Vlassoff M; Kalyanwala S; Browne A
    Lancet Glob Health; 2018 Jan; 6(1):e111-e120. PubMed ID: 29241602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessing abortion in a highly restrictive legal regime: characteristics of women and pregnant people in Malta self-managing their abortion through online telemedicine.
    Dibben A; Stabile I; Gomperts R; Kohout J
    BMJ Sex Reprod Health; 2023 Jul; 49(3):176-182. PubMed ID: 36792359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.